d-Threonine aldolase from the green alga Chlamydomonas reinhardtii (CrDTA) catalyzes the interconversion of several -hydroxy-d-amino acids (e.g. d-threonine) and glycine plus the corresponding aldehydes. Recombinant CrDTA was overexpressed in Escherichia coli and purified to homogeneity; it was subsequently crystallized using the hanging-drop vapour-diffusion method at 295 K. Data were collected and processed at 1.85 Å resolution. Analysis of the diffraction pattern showed that the crystal belonged to space group P1, with unit-cell parameters a = 64.79, b = 74.10, c = 89.94 Å , = 77.07, = 69.34, = 71.93 . The asymmetric unit contained four molecules of CrDTA. The Matthews coefficient was calculated to be 2.12 Å 3 Da À1 and the solvent content was 41.9%.
Introduction
Threonine contains two chiral centres and exists as four stereoisomers (l-, l-allo-, d-and d-allo-threonine) . The interconversion of several -hydroxy--amino acids (e.g. threonine) and glycine plus the corresponding aldehydes (e.g. acetaldehyde) is catalyzed by threonine aldolases . In general, threonine aldolases are classified into l-and d-type enzymes according to their stereospecificity at the -carbon. Depending on their stereospecificity at the -carbon of threonine, l-type threonine aldolases can be further classified into three types (Dü ckers et al., 2010) : l-threonine-specific and l-allo-threonine-specific enzymes [l-threonine aldolase (EC 4.1.2.5) and l-allo-threonine aldolase (EC 4.1.2.49), respectively], and low-specificity l-threonine aldolase (EC 4.1.2.48), which accepts both l-threonine and l-allo-threonine as substrates. Regarding the d-type enzymes, only low-specificity d-threonine aldolases (DTAs; EC 4.1.2.42) have been found to date (Fesko, 2016) .
DTA is considered to be a powerful tool for catalyzing the cleavage or formation of C-C bonds in synthetic organic chemistry (Dü ckers et al., 2010; Kataoka et al., 2016) . The cleavage reaction is important for the chiral resolution of -hydroxy--amino acid intermediates that are necessary for the production of thiamphenicol, an antibiotic, and l-threo-3,4-dihydroxyphenylserine, a therapeutic drug for Parkinson's disease (Liu et al., 1999; Liu, Odani et al., 2000) . Moreover, the synthesis reaction results in the production of various useful -hydroxy--amino acids that are active pharmaceutical ingredients used in drug development (Goldberg et al., 2015) . The enzymatic properties of DTA in several bacteria (e.g. Arthrobacter sp. DK-38) and in the green alga Chlamydomonas reinhardtii have been studied in detail. For example, these studies revealed that DTA requires pyridoxal 5 0 -phosphate (PLP) and several divalent metal cations, such as manganese ions, for catalysis (Kataoka et al., 1997; Hirato et al., 2016) . The bacterial DTA from Arthrobacter sp. DK-38 was significantly inhibited by thiol reagents, suggesting that a cysteine residue exists in the active centre of the enzyme. However, thiol reagents had no effect on the eukaryotic DTA from C. reinhardtii (CrDTA). Furthermore, the turnover number of CrDTA using d-allo-threonine as a substrate was sixfold higher than that with d-threonine, although there was little difference in specific activity between d-threonine and d-allo-threonine as substrates for bacterial DTAs (Liu et al., 1998; Liu, Odani et al., 2000) . The amino-acid sequence of CrDTA had comparatively low sequence identity to Alcaligenes xylosoxidans DTA (40% sequence identity), whereas the bacterial DTA from A. xylosoxidans showed high sequence identity to another bacterial DTA from Arthrobacter sp. (91% sequence identity). These results suggest that structural information on CrDTA may be helpful in generating strictly stereoselective d-or d-allo-threonine aldolases using rational protein design.
The recent publication of the crystal structure of a bacterial DTA from A. xylosoxidans identified a metal-binding site in the active site, which was consistent with previous observations that divalent metal ions are essential for DTA activity (PDB entry 4v15; Uhl et al., 2015) . However, the current limited structural information on DTAs makes it difficult to understand the structural differences between bacterial and eukaryotic DTAs and to develop stereoselective d-or d-allothreonine aldolases. Thus, more information on the crystal structure of DTA needs to be obtained in order to solve this problem. Here, we report the key steps, such as expression, purification, crystallization and preliminary X-ray analysis, in the structural characterization of CrDTA.
Materials and methods
2.1. Macromolecule production 2.1.1. Gene expression of CrDTA. The gene encoding CrDTA with codons optimized for expression in Escherichia coli was digested with NdeI and XhoI, and the resulting fragment was ligated into the plasmid vector pET-41b(+), previously digested with the same restriction enzymes, to construct the expression vector pCrDTA (Hirato et al., 2016) . The plasmid vector was transferred into E. coli BL21 (DE3) competent cells. Single cell clones were selected from LuriaBertani (LB) plates containing 25 mg ml À1 kanamycin. The clone was cultured in LB medium containing 25 mg ml À1 kanamycin for 16 h at 298 K and then harvested by centrifugation (8000g, 10 min) and stored at 193 K until use.
2.1.2. Purification of CrDTA. E. coli cells expressing CrDTA were suspended in 100 mM Tris-HCl buffer pH 8.0 containing 50 mM PLP and 1 mM phenylmethylsulfonylfluoride and disrupted by sonication at 80 W for 80 cycles of 30 s followed by cooling for 30 s. After centrifugation, the cell-free extract was fractionated by ammonium sulfate precipitation (25-60% saturation). The enzyme fraction was resuspended in 50 mM Tris-HCl buffer pH 8.0 containing 20 mM PLP and dialyzed in the same buffer. The enzyme solution was centrifuged and applied onto a HiTrap DEAE FF column equilibrated with 50 mM Tris-HCl buffer pH 8.0 containing 20 mM PLP and eluted with a linear gradient of 0-500 mM NaCl in the same buffer at a flow rate of 1 ml min À1 . The active fractions were collected and analyzed by SDS-PAGE (Fig. 1) and enzyme assay. Enzymatic activity was SDS-PAGE of recombinant CrDTA produced in E. coli after purification. Purified protein (0.6 mg) was analyzed on a 10% gel. Lane M contains molecular-mass marker (labelled in kDa). The gel was visualized with Coomassie Brilliant Blue. determined for each fraction using the coupling method with yeast alcohol dehydrogenase (Liu et al., 1998) . The active fractions were pooled and dialyzed against 20 mM Tris-HCl buffer pH 8.0 containing 20 mM PLP and 100 mM MnCl 2 . The purified protein was concentrated to 10-20 mg ml À1 using an Amicon Ultra-15 30K centrifugal filter (Millipore, USA) for use in crystallization. Details of macromolecule production are listed in Table 1 . The concentration of protein was determined by the Bradford assay (Bradford, 1976) after each purification step.
Crystallization
Crystallization experiments were performed in 24-well plates at 295 K using the hanging-drop vapour-diffusion method. To screen for crystals of CrDTA, the protein was concentrated to 11 mg ml À1 . 2 ml protein solution was mixed with an equal volume of reservoir solution and equilibrated against 100 ml reservoir solution. Initial crystallization screening was performed using three commercial crystallization screens from Hampton Research (Crystal Screen, Crystal Screen 2 and PEG/Ion) and a modified PEG/Ion kit using PEG 1540 as precipitant. Crystals were obtained under several conditions, and the best crystal was obtained using the modified PEG/Ion kit [0.2 M magnesium nitrate, 20%(w/v) PEG 1540] in 9 d. For optimization, the concentration of the crystallization reagent, the pH and the type of the buffer system were varied, along with the addition of various alcohols and competitive inhibitors, and the hanging drops were set up with 1 ml 50 mM dl-2,3-diaminopropionic acid, which is a substrate analogue of the enzyme, as the additive solution. Crystals suitable for X-ray diffraction were finally harvested within 13 d (Fig. 2) . Details of the final crystallization process are listed in Table 2 .
Data collection and processing
X-ray diffraction data were collected from the crystal at a wavelength of 1.00000 Å using an ADSC Quantum 210r CCD detector on beamline NE-12A of the Photon FactoryAdvanced Ring (KEK PF-AR), Tsukuba, Japan. A total of 540 images were collected at a crystal-to-detector distance of 214 mm with an oscillation range of 0.25 and an exposure time of 1 s per image. The diffraction data were processed with XDS (Kabsch, 2010) , POINTLESS (Evans, 2006) and SCALA (Evans, 2006) within the CCP4 package (Winn et al., 2011) . Data-collection and processing statistics are summarized in Table 3 .
Results and discussion
Recombinant CrDTA protein expressed in E. coli was purified to homogeneity via ammonium sulfate fractionation and anion-exchange chromatography. During DEAE-Sepharose chromatography, the protein was eluted at 100-300 mM NaCl, with the peak being at approximately 187 mM. The protein yield was 1.8 mg from a 1 l LB medium culture. SDS-PAGE analysis with Coomassie Brilliant Blue staining identified the purified protein as a single band of approximately 45 kDa, which corresponds to the calculated molecular mass of the recombinant CrDTA monomer (Fig. 1) . The protein band on the SDS-PAGE was analyzed using a protein sequencer; the N-terminal sequence of the protein band was identical to that deduced from the CrDTA gene (Hirato et al., 2016) . ) 20.0
In the initial crystallization screening, clusters of plateshaped crystals appeared under conditions using PEG 4000 and 2-propanol. The condition was optimized to produce single crystals, and rod-shaped crystals were obtained when a reservoir solution consisting of 24%(w/v) PEG 1540, 20%(v/v) 2-methyl-2,4-pentanediol, 0.2 M magesium nitrate was used (Fig. 2) . A crystal diffracting to a resolution limit of 1.85 Å was finally obtained (Fig. 3) . Analysis of the diffraction pattern showed that the crystal belonged to space group P1, with unitcell parameters a = 64. 79, b = 74.10, c = 89.94 Å , = 77.07, = 69.34, = 71.93 . Assuming the presence of four molecules per asymmetric unit, the calculated Matthews coefficient was 2.12 Å 3 Da À1 (Matthews, 1968) , giving an estimated solvent content of 41.9%.
The structure was solved by the molecular-replacement method using MOLREP (Vagin & Teplyakov, 2010) with the structure of DTA from A. xylosoxidans (PDB entry 4v15), which shares 40% identity with CrDTA, as a search model (Uhl et al., 2015) . The results of molecular replacement showed a clear solution. The R factor after an initial round of rigid-body refinement was 49.36%. The crystal contained two dimers per asymmetric unit. The molecular mass of the purified enzyme was determined via gel filtration to be 60 kDa (Hirato et al., 2016) , suggesting that CrDTA exists in a monomer-dimer equilibrium. Previous studies indicated that the bacterial DTAs from A. xylosoxidans and Arthrobacter sp. were active as monomers (Liu, Odani et al., 2000; Kataoka et al., 1997) , but the crystal structure of DTA from A. xylosoxidans was predicted to be a stable dimer in solution (Uhl et al., 2015) . Our results indicate that the assembly of CrDTA molecules was similar to that of bacterial DTAs. Structural analysis and refinement are now in progress.
